M, F., S, S., N, S., K, H., H, Y., H, O., . . . H, S. (2013). Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations. Dove Medical Press.
Cita Chicago Style (17a ed.)M, Fukuda, Shibata S, Shibata N, Hagihara K, Yaguchi H, Osada H, Takahashi N, Kubo E, y Sasaki H. Safety Comparison of Additives in Antiglaucoma Prostaglandin (PG) Analog Ophthalmic Formulations. Dove Medical Press, 2013.
Cita MLA (8a ed.)M, Fukuda, et al. Safety Comparison of Additives in Antiglaucoma Prostaglandin (PG) Analog Ophthalmic Formulations. Dove Medical Press, 2013.
Precaución: Estas citas no son 100% exactas.